| Cash Flow | 2025-10-31 |
|---|---|
| Gain on sale of property and equipment | 54 |
| Gain on settlement of convertible notes payable | 34 |
| Stock-based compensation | 598 |
| Trade accounts receivable | -214 |
| Inventory | -9 |
| Prepaid expenses and other current assets | -273 |
| Prepaid clinical trial costs (current and non-current) | -231 |
| Other receivables | -1,206 |
| Other assets | -5 |
| Accounts payable and accrued expenses | 457 |
| Other current liabilities | -3 |
| Due to related parties | 28 |
| Accrued expenses, noncurrent | 3 |
| Convertible notes payable | 8 |
| Consolidated net loss | -9,797 |
| Depreciation and amortization | 50 |
| Realized gain on available-for-sale securities | 0 |
| Amortization of discount on available-for-sale securities | 0 |
| Unrealized loss on equity investments - cyclo | 0 |
| Unrealized loss on convertible notes, due from cyclo | 0 |
| Interest receivable | 0 |
| Other liabilities | 0 |
| Net cash used in operating activities | -6,806 |
| Proceeds from sale of property and equipment | 70 |
| Purchase of preferred shares and warrants from nina medical | 500 |
| Purchase of property and equipment | 0 |
| Purchases of available-for-sale securities | 0 |
| Proceeds from the sale and maturities of available-for-sale securities | 0 |
| Purchase of intangible assets | 0 |
| Issuance of convertible notes, due from cyclo | 0 |
| Net cash (used in) provided by investing activities | -430 |
| Payments for taxes related to shares withheld for employee taxes | 28 |
| Cash paid to settle convertible notes payable | 2 |
| Net cash used in financing activities | -30 |
| Effect of exchange rate changes on cash and cash equivalents | 36 |
| Net increase (decrease) in cash and cash equivalents | -7,230 |
| Cash and cash equivalents at beginning of period | 52,769 |
| Cash and cash equivalents at end of period | 45,539 |
Rafael Holdings, Inc. (RFL)
Rafael Holdings, Inc. (RFL)